{
  "id" : "mets_hat",
  "algorithm" : "eod_public",
  "version" : "1.2",
  "name" : "EOD Mets",
  "title" : "EOD Mets",
  "notes" : "**Note:** Most pleural effusions are due to tumor. When the cytopathological examinations of pleural fluid are negative for tumor, the effusion should be excluded as a staging element and the tumor should not be classified as metastasis.\n* The physician statement of pleural effusion can be used to code this data item\n* If the physician feels the pleural effusion is due to tumor, despite negative cytology, the physicianâ€™s assessment can be used to code EOD Mets\n* If pleural fluid cytology is described as suspicious/suspicious for mesothelioma, code 70",
  "footnotes" : "(1) Fritz AG, Ries LAG (eds). **SEER Extent of Disease 1988: Codes and Coding Instructions (3rd Edition, 1998)**, National Cancer Institute, NIH Pub. No. 98-2313, Bethesda, MD, 1998\n\n(2) Young JL Jr, Roffers SD, Ries LAG, Fritz AG, Hurlbut AA (eds.). **SEER Summary Staging Manual-2000: Codes and Coding Instructions**, National Cancer Institute, NIH Pub. No. 01-4969, Bethesda, MD, 2001.\n\n(3) Collaborative Stage Work Group of the American Joint Committee on Cancer. **Collaborative Stage Data Collection System User Documentation and Coding Instructions, version 02.05**. American Joint Committee on Cancer (Chicago, IL)\n\n(4) Gress, D.M., Edge, S.B., Gershenwald, J.E., et al. **Principles of Cancer Staging**. In: Amin, M.B., Edge, S.B., Greene, F.L., et al. (Eds.) AJCC Cancer Staging Manual. 8th Ed. New York: Springer; 2017: 3-30\n\n(5) Rusch, V.W., et al. **Malignant Plural Mesothelioma**. In: Amin, M.B., Edge, S.B., Greene, F.L., et al. (Eds.) AJCC Cancer Staging Manual. 8th Ed. New York: Springer; 2017: 457-468",
  "last_modified" : "2018-05-09T15:33:19.255Z",
  "definition" : [ {
    "key" : "eod_mets",
    "name" : "Code",
    "type" : "INPUT"
  }, {
    "key" : "description",
    "name" : "Description",
    "type" : "DESCRIPTION"
  }, {
    "key" : "eod_2018_m",
    "name" : "EOD 2018 M",
    "type" : "ENDPOINT"
  }, {
    "key" : "ss2018_m",
    "name" : "SS2018 M",
    "type" : "ENDPOINT"
  } ],
  "rows" : [ [ "00", "No distant metastasis\nUnknown if distant metastasis", "VALUE:M0", "VALUE:NONE" ], [ "10", "Distant lymph node\n- Cervical   \n- Distant lymph node(s), NOS", "VALUE:M1", "VALUE:D" ], [ "70", "Contralateral lung\nContralateral pleura/chest wall (discontinuous involvement)\nLung (discontinuous ipsilateral lung tumors)\nMediastinal organs (discontinuous involvement)\nPeritoneum (discontinuous extension of tumor)\n\nMesothelioma WITH malignant pleural fluid\nPericardial effusion, malignant\nPleural effusion (see note)\n\nCarcinomatosis\n\nDistant metastasis WITH or WITHOUT distant lymph node(s)\n\nDistant metastasis, NOS", "VALUE:M1", "VALUE:D" ], [ "99", "Death Certificate Only", "VALUE:M0", "VALUE:U" ] ]
}